Literature DB >> 4462255

Orbital retinoblastoma.

R M Ellsworth.   

Abstract

Entities:  

Mesh:

Year:  1974        PMID: 4462255      PMCID: PMC1311388     

Source DB:  PubMed          Journal:  Trans Am Ophthalmol Soc        ISSN: 0065-9533


× No keyword cloud information.
  2 in total

1.  Recurrent retinoblastoma. A case with five-year survival.

Authors:  D S OLIVER
Journal:  Am J Ophthalmol       Date:  1962-02       Impact factor: 5.258

2.  Retinoblastoma in Nigeria: problems of treatment.

Authors:  H C Kodilinye
Journal:  Am J Ophthalmol       Date:  1967-03       Impact factor: 5.258

  2 in total
  8 in total

Review 1.  Chemotherapy for retinoblastoma: a current topic.

Authors:  P T Finger; G Czechonska; H Demirci; A Rausen
Journal:  Drugs       Date:  1999-12       Impact factor: 9.546

2.  Enucleation vs Ophthalmic Artery Chemosurgery for Advanced Intraocular Retinoblastoma: A Retrospective Analysis.

Authors:  Nicolas Alessandro Yannuzzi; Jasmine H Francis; Brian P Marr; Irina Belinsky; Ira J Dunkel; Yves Pierre Gobin; David Harold Abramson
Journal:  JAMA Ophthalmol       Date:  2015-09       Impact factor: 7.389

3.  Orbital retinoblastoma: Present status and future challenges - A review.

Authors:  Mohammad J Ali; Santosh G Honavar; Vijay A P Reddy
Journal:  Saudi J Ophthalmol       Date:  2010-10-13

4.  Orbital Pseudocellulitis: A Retinoblastoma-Associated Masquerade Syndrome.

Authors:  Francesco Martino; Maria Chiara Gelmi; Paolo Galluzzi; Sonia De Francesco; Clelia Miracco; Doris Hadjistilianou
Journal:  Ocul Oncol Pathol       Date:  2020-10-08

Review 5.  Retinoblastoma: achieving new standards with methods of chemotherapy.

Authors:  Swathi Kaliki; Carol L Shields
Journal:  Indian J Ophthalmol       Date:  2015-02       Impact factor: 1.848

Review 6.  Orbital retinoblastoma: An update.

Authors:  Santosh G Honavar; Fairooz P Manjandavida; Vijay Anand P Reddy
Journal:  Indian J Ophthalmol       Date:  2017-06       Impact factor: 1.848

7.  Orbital relapse of retinoblastoma in patients with high-risk histopathology features.

Authors:  Maria Vittoria Cicinelli; Swathi Kaliki
Journal:  Ther Adv Ophthalmol       Date:  2019-04-26

Review 8.  Retinoblastoma in Asia.

Authors:  Mukesh Jain; Duangnate Rojanaporn; Bhavna Chawla; Gangadhar Sundar; Lingam Gopal; Vikas Khetan
Journal:  Eye (Lond)       Date:  2018-11-01       Impact factor: 3.775

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.